Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark

被引:28
作者
Sorrig, Rasmus [1 ,2 ]
Klausen, Tobias W. [3 ]
Salomo, Morten [1 ]
Vangsted, Annette [1 ,2 ]
Gimsing, Peter [1 ]
机构
[1] Rigshosp, Dept Hematol, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Herlev Hosp, Hematol Res Lab, Herlev, Denmark
基金
新加坡国家研究基金会;
关键词
blood stream infections; multiple myeloma; risk factors; WORKING GROUP; DIAGNOSIS; THERAPY; COMPLICATIONS; EPIDEMIOLOGY; MORTALITY; DATABASE; COHORT; ERA;
D O I
10.1111/ejh.13066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Multiple myeloma (MM) patients are at high risk of developing infections. The risk factors for blood stream infections (BSI) in MM patients are, however, less described. The aim of this study was to analyze the epidemiology of and risk factors for BSI in an unselected MM population. Methods Nationwide Danish MM data of 1154 patients diagnosed from 2010 to 2013 were linked with nationwide data on blood cultures (BCs; from 2010 to 2016) to assess the peak period of having a BC taken and BC positive for pathogenic microorganisms. Results The highest number of BC was taken in the period from day -30 to day +180 from date of MM diagnosis. Risk factors for having a BC sampling within the peak period were as follows: immunoparesis (HR 1.5 [1.1-2.1]; P = .007), ISS-III (HR 1.3 [1.0-1.7]; P = .035), high creatinine (HR 1.4 (1.0-2.0); P = .046), and high lactate dehydrogenase (LDH) (HR 2.8 (1.6-4.7; P < .001). Risk factors for positive BC during the peak period were ISS-III (HR 2.0 (1.1-3.7); P = .023) and high LDH (HR 3.4 [1.1-10.3]; P = .028). Conclusions Our results show that MM patients with aggressive disease presentation are at the highest risk of developing BSI. Furthermore, our study implies that MM is diagnosed in relation to a serious infection for a large number of patients.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 28 条
[1]   Causes of early death in multiple myeloma patients treated with high-dose therapy followed by autologous stem cell transplantation: A study based on the nationwide Danish Multiple Myeloma Registry [J].
Andersen, Kristian Thidemann ;
Klausen, Tobias ;
Abildgaard, Niels ;
Andersen, Mette Klarskov ;
Andersen, Niels Frost ;
Frolund, Ulf Christian ;
Helleberg, Carsten ;
Kjeldsen, Eigil ;
Pedersen, Per ;
Helm-Petersen, Sissel ;
Svirskaite, Asta ;
Preiss, Birgitte ;
Gimsing, Peter ;
Vangsted, Annette Juul .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) :E611-E614
[2]   Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party [J].
Augustson, BM ;
Begum, G ;
Dunn, JA ;
Barth, NJ ;
Davies, F ;
Morgan, G ;
Behrens, J ;
Smith, A ;
Child, JA ;
Drayson, MT .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9219-9226
[3]   Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors [J].
Backhaus, Erik ;
Berg, Stefan ;
Andersson, Rune ;
Ockborn, Gunilla ;
Malmstrom, Petter ;
Dahl, Mats ;
Nasic, Salmir ;
Trollfors, Birger .
BMC INFECTIOUS DISEASES, 2016, 16
[4]   A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) [J].
Baron, Ellen Jo ;
Miller, J. Michael ;
Weinstein, Melvin P. ;
Richter, Sandra S. ;
Gilligan, Peter H. ;
Thomson, Richard B., Jr. ;
Bourbeau, Paul ;
Carroll, Karen C. ;
Kehl, Sue C. ;
Dunne, W. Michael ;
Robinson-Dunn, Barbara ;
Schwartzman, Joseph D. ;
Chapin, Kimberle C. ;
Snyder, James W. ;
Forbes, Betty A. ;
Patel, Robin ;
Rosenblatt, Jon E. ;
Pritt, Bobbi S. .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (04) :485-488
[5]   Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients [J].
Blimark, Cecilie ;
Holmberg, Erik ;
Mellqvist, Ulf-Henrik ;
Landgren, Ola ;
Bjoekholm, Magnus ;
Hultcrantz, Malin ;
Kjellander, Christian ;
Turesson, Ingemar ;
Kristinsson, Sigurdur Y. .
HAEMATOLOGICA, 2015, 100 (01) :107-113
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]  
Dansk Myelomatose Studiegruppe, DIAGN BEH MYEL RETN
[8]   INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA [J].
FAHEY, JL ;
SCOGGINS, R ;
UTZ, JP ;
SZWED, CF .
AMERICAN JOURNAL OF MEDICINE, 1963, 35 (05) :698-+
[9]   The Danish National Multiple Myeloma Registry [J].
Gimsing, Peter ;
Holmstrom, Morten O. ;
Klausen, Tobias Wirenfelt ;
Andersen, Niels Frost ;
Gregersen, Henrik ;
Pedersen, Robert Schou ;
Plesner, Torben ;
Pedersen, Per Trollund ;
Frederiksen, Mikael ;
Frolund, Ulf ;
Helleberg, Carsten ;
Vangsted, Annette ;
Brown, Peter de Nully ;
Abildgaard, Niels .
CLINICAL EPIDEMIOLOGY, 2016, 8 :583-587
[10]   Utilization of blood cultures in Danish hospitals: a population-based descriptive analysis [J].
Gubbels, S. ;
Nielsen, J. ;
Voldstedlund, M. ;
Kristensen, B. ;
Schonheyder, H. C. ;
Vandenbroucke-Grauls, C. M. J. E. ;
Arpi, M. ;
Bjornsdottir, M. K. ;
Knudsen, J. Dahl ;
Dessau, R. B. ;
Jensen, T. Gorm ;
Kjaeldgaard, P. ;
Lemming, L. ;
Moller, J. K. ;
Hansen, D. Schroder ;
Molbak, K. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (04) :344.e13-344.e21